Late de novo minimal change disease in a renal allograft

Saudi J Kidney Dis Transpl. 2009 Mar;20(2):266-9.

Abstract

Among the causes of the nephrotic syndrome in renal allografts, minimal change disease is a rarity with only few cases described in the medical literature. Most cases described have occurred early in the post-transplant course. There is no established treatment for the condition but prognosis is favorable. We describe a case of minimal change disease that developed 8 years after a successful transplantation of a renal allograft in a middle-aged woman. The nephrotic syndrome was accompanied by deterioration of allograft function. Treatment with mycophenolate mofetil was successful in inducing remission and stabilizing allograft function.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Failure, Chronic / surgery*
  • Kidney Glomerulus / pathology
  • Kidney Transplantation / pathology*
  • Middle Aged
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Nephrosis, Lipoid / blood
  • Nephrosis, Lipoid / drug therapy
  • Nephrosis, Lipoid / pathology*
  • Prodrugs
  • Remission Induction / methods
  • Time Factors
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Prodrugs
  • Mycophenolic Acid